CV
CVS.US CVS Health Corp
- Market cap
- USD 114B
- P/E
- 10.4x
- P/B
- 1.43x
- ROE
- 13.4%
- Dividend yield
- 2.97%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CVS.US undervalued?
Graham numberCVS.US trades 18.9% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CVS Health Corp fundamental analysis
No fundamental analysis for CVS Health Corp yet.
CVS Health Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CVS Health Corp
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college…
Full company profileCVS Health Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CVS Health Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 178B | 185B | 195B | 257B | 269B | 292B | 322B | 358B | 373B | 402B | 420B |
| Gross Profit | 28.8B | 28.5B | 31.5B | 45.5B | 49.0B | 52.1B | 54.5B | 54.4B | 51.4B | 55.4B | 61.7B |
| Operating Income | 10.4B | 9.54B | 4.02B | 12.0B | 13.9B | 13.3B | 7.95B | 13.7B | 8.52B | 10.4B | 17.3B |
| EBITDA | 12.2B | 11.8B | 6.74B | 16.4B | 17.1B | 17.5B | 12.3B | 13.7B | 13.7B | 9.86B | 21.9B |
| Net Income | 5.32B | 6.62B | -594M | 6.63B | 7.18B | 8.00B | 4.31B | 8.34B | 4.61B | 1.77B | 10.8B |
| EPS | 4.93 | 6.47 | -0.57 | 5.08 | 5.46 | 6.02 | 3.26 | 6.47 | 3.66 | 1.39 | 8.38 |
| Balance Sheet | |||||||||||
| Total Assets | 94.5B | 95.1B | 196B | 222B | 231B | 233B | 228B | 250B | 253B | 254B | 258B |
| Total Liabilities | 57.6B | 57.4B | 138B | 158B | 161B | 158B | 157B | 173B | 177B | 178B | 177B |
| Shareholders' Equity | 36.8B | 37.7B | 58.2B | 63.9B | 69.4B | 75.1B | 71.5B | 76.5B | 75.6B | 75.2B | 80.5B |
| Cash & Short-term Investments | 3.46B | 1.81B | 6.58B | 8.06B | 10.9B | 12.5B | 15.7B | 11.5B | 11.0B | 10.6B | 14.9B |
| Total Debt | 27.5B | 27.0B | 73.4B | 89.0B | 85.0B | 76.0B | 70.7B | 79.4B | 82.9B | 80.0B | 75.3B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 10.1B | 8.01B | 8.87B | 12.8B | 15.9B | 18.3B | 16.2B | 13.4B | 9.11B | 10.6B | 20.4B |
| Capital Expenditure | 2.22B | 1.92B | 2.04B | 2.46B | 2.44B | 2.52B | 2.73B | 3.03B | 2.78B | 2.83B | 3.14B |
| Free Cash Flow | 7.92B | 6.09B | 6.83B | 10.4B | 13.4B | 15.7B | 13.5B | 10.4B | 6.33B | 7.81B | 17.3B |
| Ratios | |||||||||||
| ROE | 14.4% | 17.6% | -1.0% | 10.4% | 10.3% | 10.7% | 6.0% | 10.9% | 6.1% | 2.4% | 13.4% |
| ROA | 5.6% | 7.0% | -0.3% | 3.0% | 3.1% | 3.4% | 1.9% | 3.3% | 1.8% | 0.7% | 4.2% |
| Net Profit Margin | 3.0% | 3.6% | -0.3% | 2.6% | 2.7% | 2.7% | 1.3% | 2.3% | 1.2% | 0.4% | 2.6% |
| Debt to Equity | 0.75x | 0.72x | 1.26x | 1.39x | 1.23x | 1.01x | 0.99x | 1.04x | 1.10x | 1.06x | 0.94x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
CVS Health Corp dividends
- Dividend yield
- 2.97%
- Forward dividend
- 2.66 USD
- Payout ratio
- 192.1%
- Ex-dividend date
- Oct 22, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 3.40B | 2.67 | 192.1% |
| 2024 | USD 3.37B | 2.67 | 73.1% |
| 2023 | USD 3.13B | 2.43 | 37.5% |
| 2022 | USD 2.91B | 2.20 | 67.4% |
| 2021 | USD 2.63B | 1.98 | 32.8% |
| 2020 | USD 2.62B | 2.00 | 36.6% |
| 2019 | USD 2.60B | 1.99 | 39.2% |
| 2018 | USD 2.04B | 1.95 | - |
| 2017 | USD 2.05B | 2.00 | 30.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Jun 7, 2005.
Who owns CVS Health Corp
- Insiders 0.06%
- Institutions 91.29%
- Public & others 8.65%
- Shares outstanding 1.28B
- Free float 1.28B
Top funds holding CVS.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 40.6M | 3.17% | +0.08% | Sep 2026 |
| Vanguard 500 Index Investor | 33.6M | 2.63% | -0.91% | Sep 2026 |
| American Funds Washington Mutual A | 31.6M | 2.47% | -0.32% | Sep 2026 |
| Dodge & Cox Stock I | 29.5M | 2.30% | -7.03% | Sep 2026 |
| American Funds Income Fd of Amer A | 23.7M | 1.85% | 0.00% | Sep 2026 |
| American Funds American Balanced A | 17.1M | 1.33% | -4.82% | Sep 2026 |
| iShares Core S&P 500 ETF | 17.1M | 1.33% | +0.17% | Oct 2026 |
| Fidelity 500 Index | 16.6M | 1.30% | +0.35% | Sep 2026 |
| State Street® SPDR® S&P 500® ETF | 15.6M | 1.22% | -0.25% | Oct 2026 |
| Vanguard MStar Value Index Investor | 12.2M | 0.95% | -0.13% | Sep 2026 |
| Vanguard Health Care Inv | 10.2M | 0.80% | +5.04% | Sep 2026 |
| American Funds American Mutual A | 9.69M | 0.76% | -7.53% | Sep 2026 |
| State Street®HlthCrSelSectSPDR®ETF | 9.36M | 0.73% | +0.88% | Oct 2026 |
| American Funds Fundamental Invs A | 8.50M | 0.66% | 0.00% | Sep 2026 |
| Vanguard Equity-Income Inv | 6.83M | 0.53% | +9.41% | Sep 2026 |
| Vanguard Institutional Index I | 6.77M | 0.53% | -0.82% | Sep 2026 |
| Vanguard Wellington Inv | 6.62M | 0.52% | +12.52% | Sep 2026 |
| BlackRock Equity Dividend Instl | 5.51M | 0.43% | -9.09% | Sep 2026 |
| Vanguard High Dividend Yield ETF | 5.22M | 0.41% | +0.27% | Sep 2026 |
| Strategic Advisers Fidelity US TtlStk | 4.63M | 0.36% | +9.02% | Sep 2026 |
Top institutions holding CVS.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 123M | 9.63% | -2.14% | Jun 2026 |
| Vanguard Capital Management, LLC | 83.3M | 6.51% | +0.81% | Jun 2026 |
| Capital World Investors | 75.0M | 5.86% | -2.97% | Jun 2026 |
| State Street Corp | 60.3M | 4.71% | +1.62% | Jun 2026 |
| Dodge & Cox | 50.0M | 3.91% | -3.41% | Jun 2026 |
| Wellington Management Company LLP | 33.8M | 2.64% | +49.78% | Jun 2026 |
| Geode Capital Management, LLC | 29.9M | 2.34% | +1.50% | Jun 2026 |
| FMR Inc | 28.9M | 2.26% | -7.30% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 26.6M | 2.08% | +2.46% | Jun 2026 |
| Capital Research Global Investors | 24.3M | 1.90% | +21.57% | Jun 2026 |
| T. Rowe Price Associates, Inc. | 24.2M | 1.89% | +1.77% | Jun 2026 |
| Bank of America Corp | 23.2M | 1.81% | +147.95% | Jun 2026 |
| JPMorgan Chase & Co | 22.1M | 1.73% | -25.11% | Jun 2026 |
| Amvescap Plc. | 20.6M | 1.61% | -18.07% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 18.6M | 1.45% | +4.38% | Jun 2026 |
| NORGES BANK | 18.0M | 1.41% | -14.09% | Jun 2026 |
| Capital Research & Mgmt Co - Division 3 | 15.4M | 1.20% | -0.03% | Jun 2026 |
| The Goldman Sachs Group Inc | 13.4M | 1.05% | +6.11% | Jun 2026 |
| Charles Schwab Investment Management Inc | 13.3M | 1.04% | -3.04% | Jun 2026 |
| Davis Selected Advisers | 11.9M | 0.93% | -3.05% | Jun 2026 |
CVS Health Corp company profile
- Company name
- CVS Health Corp
- Ticker
- CVS.US
- Exchange
- USA Stocks
- Listed since
- Dec 17, 1984
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 219,000
- Fiscal year end
- December
- Address
- One CVS Drive, Woonsocket, RI, United States, 02895
- Phone
- 401 765 1500
- Website
- cvshealth.com
About CVS Health Corp
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
CVS Health Corp management
10- Mr. J. David Joyner CEBSCEO, President & Chairman · born 1965
- Mr. Brian O. NewmanExecutive VP & CFO · born 1969
- Mr. Tilak MandadiEVP of Ventures and Chief Experience & Technology Officer · born 1964
- Mr. Prem S. Shah Pharm.DExecutive VP & Group President · born 1980
- Mr. Steven Hale Nelson M.B.A.Executive VP & President of Aetna · born 1959
- Mr. James David ClarkSenior VP, Controller & Chief Accounting Officer · born 1965
- Mr. David A. FalkowskiExecutive VP & Chief Compliance Officer
- Mr. Samrat S. Khichi Esq.Executive VP of Corporate Affairs & Chief Legal Officer · born 1967
- Ms. Heidi B. CapozziExecutive VP & Chief People Officer · born 1970
- Dr. Sreekanth K. Chaguturu M.D.President of Health Care Delivery & Executive VP · born 1979